New AI technology sheds light on drug development

Will artificial intelligence (AI) change the traditional trial–and–error drug development process and become a revolutionary force in the pharmaceutical sector? Active learning and interpretable AI are the two critical paradigms that lead to the positive answer, according to a perspective article recently published in Health Data Science. “Promising progress has been made in using AI for drug design recently. However, […]
Continue reading »